| GTO ID | GTC2249 |
| Trial ID | NCT04163094 |
| Disease | Ovarian Cancer |
| Therapy | mRNA vaccine |
| Treatment | W_ova1 |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | Ovarian Cancer Treatment With a Liposome Formulated mRNA Vaccine in Combination With (Neo-)Adjuvant Chemotherapy |
| Year | 2019 |
| Country | Netherlands |
| Company sponsor | University Medical Center Groningen |
| Other ID(s) | OLIVIA-UMCG-01|2017-004585-10 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||